Skip to main content
Equibles

Pictet Asset Management Holding SA

Position in SYRE — Spyre Therapeutics, Inc.

CIK 1993888 CAROUGE, V8
Back to SYRE Full portfolio

Position in SYRE

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$55,766,091
+$30,967,316 QoQ
Shares Held
628,138
+27.8% QoQ
Ownership
0.712%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#35
of 266 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Pictet Asset Management Holding SA holds $3,960,623,527 across 131 Biotechnology names. SYRE ranks #29 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 539,255 $267,864,136
2 RVMD
Revolution Medicines, Inc.
 1,014,894 $190,069,348
3 ARGX
Argenx SE
 198,282 $183,960,091
4 INSM
INSMED Inc
 1,220,353 $130,114,036
5 IONS
Ionis Pharmaceuticals Inc
 1,596,998 $126,625,971
6 ROIV
Roivant Sciences Ltd.
 3,468,340 $122,744,552
7 BBIO
BridgeBio Pharma, Inc.
 1,448,126 $107,856,424
8 RYTM
Rhythm Pharmaceuticals, Inc.
 957,785 $106,342,868

All Filings in SYRE

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $55,766,091 628,138
2026-03-31 $24,798,775 491,649
2025-12-31 $29,941,329 913,960
2025-09-30 $17,367,013 1,036,218
2025-06-30 $16,159,261 1,079,443
2025-03-31 $17,246,572 1,068,892
2024-12-31 $25,424,646 1,092,124
2024-09-30 $24,284,013 825,706
2024-06-30 $9,089,365 386,617